Overexpression of TEX101, a potential novel cancer marker, in head and neck squamous cell carcinoma

Cancer Biomarkers

Volumn 12, Issue 3, 2012, Pages 141-148

  Yoshitake, Hiroshi ^a   Yokoi, Hidenori ^b   Ishikawa, Hitoshi ^c   Maruyama, Mayuko ^a,d,e   Endo, Shuichiro ^a,d   Nojima, Michio ^e   Yoshida, Koyo ^e   Yoshikawa, Hiroshi ^e   Suzuki, Fujihiko ^f   Takamori, Kenji ^a   Fujiwara, Hiroshi ^g   Araki, Yoshihiko ^a,d  

^a JUNTENDO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Yamagata Saisei Hospital   (Japan)

^d JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g NIPPON MEDICAL SCHOOL GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

head and neck squamous cell carcinoma; Ly 6 urokinase type plasminogen activator receptor family; TEX101; three fingered protein

Indexed keywords

MEMBRANE PROTEIN; POLYCLONAL ANTIBODY; TEX101 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER PROGNOSIS; CANCER TISSUE; CONTROLLED STUDY; EXTERNAL AUDITORY CANAL; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MOUTH CAVITY; NASOPHARYNX; NOSE CAVITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SQUAMOUS EPITHELIUM; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

MURINAE;

EID: 84876400550     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130302     Document Type: Article

References (32)

1. A. Kurita, T. Takizawa, T. Takayama, K. Totsukawa, S. Matsubara, H. Shibahara, M.C. Orgebin-Crist, F. Sendo, Y. Shinkai, and Y. Araki, Identification, cloning, and initial characterization of a novel mouse testicular germcell-specific antigen, Biol Reprod 64 (2001), 935-945. (Pubitemid 32174067)
2. T. Takayama, T. Mishima, M. Mori, H. Jin, H. Tsukamoto, K. Takahashi, T. Takizawa, K. Kinoshita, M. Suzuki, I. Sato, S. Matsubara, Y. Araki, and T. Takizawa, Sexually dimorphic expression of the novel germ cell antigen TEX101 during mouse gonad development, Biol Reprod 72 (2005), 1315-1323. (Pubitemid 40696074)
3. System Biology and Medicine Database, http://www.lsbm. org/site e/index.html.
4. H. Jin, H. Yoshitake, H. Tsukamoto, M. Takahashi, M. Mori, T. Takizawa, K. Takamori, H. Ogawa, K. Kinoshita, and Y. Araki,Molecular characterization of a germ-cell-specific antigen, TEX101, from mouse testis, Zygote 14 (2006), 201-208. (Pubitemid 44032296)
5. H. Tsukamoto, T. Takizawa, K. Takamori, H. Ogawa, and Y. Araki, Genomic organization and structure of the 5'-flanking region of the TEX101 gene: Alternative promoter usage and splicing generate transcript variants with distinct 5'-untranslated region, Mol Reprod Dev 74 (2007), 154-162. (Pubitemid 46047985)
6. M. Kjaergaard, L.V. Hansen, B. Jacobsen, H. Gardsvoll, and M. Ploug, Structure and ligand interactions of the urokinase receptor (uPAR), Front Biosci 13 (2008), 5441-5461.
7. A.Galat, The three-fingered protein domain of the human genome, Cell Mol Life Sci 65 (2008), 3481-3493.
8. T. Reichling, K.H. Goss, D.J. Carson, R.W. Holdcraft, C. Ley-Ebert, D. Witte, B.J. Aronow, and J. Groden, Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors, Cancer Res 65 (2005), 166-176. (Pubitemid 40070807)
9. R. Eshel, A. Zanin, D. Kapon, O. Sagi-Assif, R. Brakenhoff, G. Van Dongen, and I.P. Witz, Human Ly-6 antigen E48 (Ly-6D) regulates important interaction parameters between endothelial cells and head-and-neck squamous carcinoma cells, Int J Cancer 98 (2002), 803-810. (Pubitemid 34286673)
10. M. Mao, M. Yu, J.H. Tong, J. Ye, J. Zhu, Q.H. Huang, G. Fu, L. Yu, S.Y. Zhao, S. Waxman, M. Lanotte, Z.Y. Wang, J.Z. Tan, S.J. Chan, and Z. Chen, RIG-E, a human homolog of the murine Ly-6 family, is induced by retinoic acid during the differentiation of acute promyelocytic leukemia cell, Proc Natl Acad Sci USA 93 (1996), 5910-5914. (Pubitemid 26190776)
11. N. Ishikawa, A. Takano, W. Yasui, K. Inai, H. Nishimura, H. Ito, Y. Miyagi, H. Nakayama, M. Fujita, M. Hosokawa, E. Tsuchiya, N. Kohno, Y. Nakamura, and Y. Daigo, Cancertestis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas, Cancer Res 67 (2007), 11601-11611.
12. J. Lee, Y. Lee, K. Yoo, K. Lee, K. Park, T. Ahn, C. Ko, and J. Park, LY-6K gene: a novel molecular marker for human breast cancer, Oncol Rep 16 (2006), 1211-1214.
13. M. Horie, K. Okutomi, Y. Taniguchi, Y. Ohbuchi, M. Suzuki, and E. Takahashi, Isolation and characterization of a new member of the human Ly6 gene family (LY6H), Genomics 53 (1998), 365-368. (Pubitemid 28527639)
14. K. Konishi, H. Yamamoto, K. Mimori, I. Takemasa, T. Mizushima, M. Ikeda, M. Sekimoto, N. Matsuura, T. Takao, Y. Doki, and M. Mori, Expression of C4.4A at the invasive front is a novel prognostic marker for disease recurrence of colorectal cancer, Cancer Sci 101 (2010), 2269-2277.
15. M.C. Boonstra, H.W. Verspaget, S. Ganesh, F.J. Kubben, A.L. Vahrmeijer, C.J. Van de Velde, P.J. Kuppen, P.H. Quax, and C.F. Sier, Clinical applications of the urokinase receptor (uPAR) for cancer patients, Curr Pharm Des 17 (2011), 1890-1910.
16. K. Tajima, Y. Obata, H. Tamaki, M. Yoshida, Y.T. Chen, M.J. Scanlan, L.J. Old, H. Kuwano, T. Takahashi, T. Takahashi, and T. Mitsudomi, Expression of cancer/testis (CT) antigens in lung cancer, Lung Cancer 42 (2003), 23-33. (Pubitemid 37153132)
17. S. Ghafouri-Fard, A. Abbasi, H. Moslehi, N. Faramarzi, S. Taba Taba Vakili, M.B. Mobasheri, and M.H. Modarressi, Elevated expression levels of testis-specific genesTEX101 and SPATA19 in basal cell carcinoma and their correlation with clinical and pathological features, Br J Dermatol 162 (2010), 772-779.
18. H. Yoshitake, H. Tsukamoto, M. Maruyama-Fukushima, K. Takamori, H. Ogawa, and Y. Araki, TEX101, a germ cellmarker glycoprotein, is associated with lymphocyte antigen 6 complex locus k within the mouse testis, Biochem Biophys Res Commun 372 (2008), 277-282.
19. A. de Nooij-Van Dalen, G. Van Dongen, S. Smeets, E. Nieuwenhuis, M. Stigter-Van Walsum, G. Snow, and R. Brakenhoff, Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma, Int J Cancer 103 (2003), 768-774. (Pubitemid 36110233)
20. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind, International Union against cancer. TNMClassification of Malignant Tumors, L.H. Sobin, M.K. Gospodarowicz, and C.Wittekind, eds., Wiley-Blackwell, New York, 2009.
21. U.K. Laemmli, Cleavage of structural proteins during the assembly of the head of bacteriophage T4, Nature 227 (1970), 680-685.
22. J.J. Durieux, N. Vita, O. Popescu, F. Guette, J. Calzada-Wack, R. Munker, R.E. Schmidt, J. Lupker, P. Ferrara, H.W. Ziegler-Heitbrock, and M.O. Labeta, The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes, Eur J Immunol 24 (1994), 2006-2012. (Pubitemid 24276527)
23. T.W.Huizinga, M. de Haas,M. Kleijer, J.H. Nuijens, D. Roos, and A.E. von dem Borne, Soluble Fc gamma receptor III in human plasma originates from release by neutrophils, J Clin Invest 86 (1990), 416-423. (Pubitemid 20271873)
24. M.E. Medof, E.I. Walter, J.L. Rutgers, D.M. Knowles, and V. Nussenzweig, Identification of the complement decayaccelerating factor (DAF) on epithelium and glandular cells and in body fluids, J ExpMed 165 (1987), 848-864. (Pubitemid 17059457)
25. M. Ploug, J. Eriksen, T. Plesner, N.E. Hansen, and K. Dano, A soluble form of the glycolipid-anchored receptor for urokinase-type plasminogen activator is secreted from peripheral blood leukocytes from patients with paroxysmal nocturnal hemoglobinuria, Eur J Biochem 208 (1992), 397-404.
26. T. Nitto, Y. Araki, Y. Takeda, and F. Sendo, Pharmacological analysis formechanisms ofGPI-80 release fromtumour necrosis factor-alpha-stimulated human neutrophils, Br J Pharmacol 137 (2002), 353-360.
27. W.J. Blot, J.K. McLaughlin, D.M. Winn, D.F. Austin, R.S. Greenberg, S. Preston-Martin, L. Bernstein, J.B. Schoenberg, A. Stemhagen, and J.F. Fraumeni, Smoking and drinking in relation to oral and pharyngeal cancer, Cancer Res 48 (1988), 3282-3287.
28. F. Lewin, S.E. Norell, H. Johansson, P. Gustavsson, J.Wennerberg, A. Biorklund, and L.E. Rutqvist, Smoking tobacco, oral snuff, and alcohol in the etiology of squamous cell carcinoma of the head and neck: a population-based case-referent study in Sweden, Cancer 82 (1998), 1367-1375. (Pubitemid 28155400)
29. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, and C.J. Meijer, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N Engl J Med 348 (2003), 518-527. (Pubitemid 36159887)
30. F. Blasi and P. Carmeliet, uPAR: a versatile signalling orchestrator, Nat Rev Mol Cell Biol 3 (2002), 932-943. (Pubitemid 35477371)
31. H.W. Smith and C.J.Marshall, Regulation of cell signaling by uPAR, Nat Rev Mol Cell Biol 11 (2010), 23-36.
32. S.H. Choi, H.K. Kong, S.Y. Park, and J.H. Park, Metastatic effect of LY-6K gene in breast cancer cells, Int J Oncol 35 (2009), 601-607.